CELZ
Price
$2.27
Change
-$0.02 (-0.87%)
Updated
Jun 4 closing price
Capitalization
5.86M
IMRN
Price
$1.76
Change
-$0.00 (-0.00%)
Updated
Jun 4 closing price
Capitalization
9.98M
85 days until earnings call
Interact to see
Advertisement

CELZ vs IMRN

Header iconCELZ vs IMRN Comparison
Open Charts CELZ vs IMRNBanner chart's image
Creative Medical Technology Holdings
Price$2.27
Change-$0.02 (-0.87%)
Volume$104.03K
Capitalization5.86M
Immuron
Price$1.76
Change-$0.00 (-0.00%)
Volume$22.98K
Capitalization9.98M
CELZ vs IMRN Comparison Chart
Loading...
CELZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CELZ vs. IMRN commentary
Jun 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CELZ is a Buy and IMRN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 05, 2025
Stock price -- (CELZ: $2.27 vs. IMRN: $1.76)
Brand notoriety: CELZ and IMRN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CELZ: 163% vs. IMRN: 70%
Market capitalization -- CELZ: $5.86M vs. IMRN: $9.98M
CELZ [@Biotechnology] is valued at $5.86M. IMRN’s [@Biotechnology] market capitalization is $9.98M. The market cap for tickers in the [@Biotechnology] industry ranges from $318.09B to $0. The average market capitalization across the [@Biotechnology] industry is $2.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CELZ’s FA Score shows that 0 FA rating(s) are green whileIMRN’s FA Score has 1 green FA rating(s).

  • CELZ’s FA Score: 0 green, 5 red.
  • IMRN’s FA Score: 1 green, 4 red.
According to our system of comparison, IMRN is a better buy in the long-term than CELZ.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CELZ’s TA Score shows that 5 TA indicator(s) are bullish.

  • CELZ’s TA Score: 5 bullish, 5 bearish.

Price Growth

CELZ (@Biotechnology) experienced а +10.73% price change this week, while IMRN (@Biotechnology) price change was -2.76% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.56%. For the same industry, the average monthly price growth was +5.22%, and the average quarterly price growth was -1.09%.

Reported Earning Dates

CELZ is expected to report earnings on Aug 30, 2023.

IMRN is expected to report earnings on Aug 29, 2025.

Industries' Descriptions

@Biotechnology (+6.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMRN($9.98M) has a higher market cap than CELZ($5.86M). IMRN YTD gains are higher at: 3.529 vs. CELZ (-1.732). CELZ has higher annual earnings (EBITDA): -5.52M vs. IMRN (-7.35M). IMRN has more cash in the bank: 7.74M vs. CELZ (6.26M). IMRN has higher revenues than CELZ: IMRN (6.54M) vs CELZ (11K).
CELZIMRNCELZ / IMRN
Capitalization5.86M9.98M59%
EBITDA-5.52M-7.35M75%
Gain YTD-1.7323.529-49%
P/E RatioN/AN/A-
Revenue11K6.54M0%
Total Cash6.26M7.74M81%
Total Debt2.74MN/A-
FUNDAMENTALS RATINGS
CELZ vs IMRN: Fundamental Ratings
CELZ
IMRN
OUTLOOK RATING
1..100
76
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
24
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9494
PRICE GROWTH RATING
1..100
6579
P/E GROWTH RATING
1..100
63100
SEASONALITY SCORE
1..100
5065

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IMRN's Valuation (24) in the Biotechnology industry is somewhat better than the same rating for CELZ (61) in the null industry. This means that IMRN’s stock grew somewhat faster than CELZ’s over the last 12 months.

IMRN's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as CELZ (100) in the null industry. This means that IMRN’s stock grew similarly to CELZ’s over the last 12 months.

IMRN's SMR Rating (94) in the Biotechnology industry is in the same range as CELZ (94) in the null industry. This means that IMRN’s stock grew similarly to CELZ’s over the last 12 months.

CELZ's Price Growth Rating (65) in the null industry is in the same range as IMRN (79) in the Biotechnology industry. This means that CELZ’s stock grew similarly to IMRN’s over the last 12 months.

CELZ's P/E Growth Rating (63) in the null industry is somewhat better than the same rating for IMRN (100) in the Biotechnology industry. This means that CELZ’s stock grew somewhat faster than IMRN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CELZ
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
87%
Momentum
ODDS (%)
Bullish Trend 1 day ago
83%
MACD
ODDS (%)
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
79%
Advances
ODDS (%)
Bullish Trend 2 days ago
85%
Declines
ODDS (%)
Bearish Trend 14 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
88%
Aroon
ODDS (%)
Bullish Trend 1 day ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
CELZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CSTE1.800.08
+4.65%
Caesarstone Ltd
INDP0.34N/A
-0.19%
Indaptus Therapeutics
IFS34.72-0.09
-0.26%
Intercorp Financial Services
AMH37.21-0.12
-0.32%
American Homes 4 Rent
SUPV11.71-0.92
-7.28%
Grupo Supervielle SA

CELZ and

Correlation & Price change

A.I.dvisor indicates that over the last year, CELZ has been loosely correlated with LABFF. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if CELZ jumps, then LABFF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CELZ
1D Price
Change %
CELZ100%
-0.87%
LABFF - CELZ
35%
Loosely correlated
N/A
EDIT - CELZ
31%
Poorly correlated
N/A
WVE - CELZ
30%
Poorly correlated
+2.77%
GNPX - CELZ
28%
Poorly correlated
-2.79%
IMRN - CELZ
25%
Poorly correlated
N/A
More

IMRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMRN has been closely correlated with LABFF. These tickers have moved in lockstep 81% of the time. This A.I.-generated data suggests there is a high statistical probability that if IMRN jumps, then LABFF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMRN
1D Price
Change %
IMRN100%
N/A
LABFF - IMRN
81%
Closely correlated
N/A
MNMD - IMRN
44%
Loosely correlated
-0.52%
VYGR - IMRN
26%
Poorly correlated
+1.22%
CELZ - IMRN
25%
Poorly correlated
-0.87%
TCRX - IMRN
24%
Poorly correlated
+1.71%
More